Deutsche Bank Ag\ Maxcyte, Inc. Transaction History
Deutsche Bank Ag\
- $245 Billion
- Q1 2025
A detailed history of Deutsche Bank Ag\ transactions in Maxcyte, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 87,343 shares of MXCT stock, worth $192,154. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87,343
Previous 98,436
11.27%
Holding current value
$192,154
Previous $409,000
41.81%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding MXCT
# of Institutions
119Shares Held
73MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY10MShares$22.1 Million1.17% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$17.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY7MShares$15.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$12.2 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$11.1 Million13.13% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $224M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...